PSI Webinar: Master protocols - theory, application and regulatory considerations
For this webinar, PSI brings together experts on master protocols from the pharmaceutical industry, academia, and regulatory agencies.
PSI is one of many organisations that are rooted within statistics and data analytics. As such, we believe that it is important for us to link with other appropriate organisations.
PSI is the association located in the UK for statisticians in the pharmaceutical industry, and therefore we have two representatives on the European Federation of Statisticians in the Pharmaceutical Industry council. EFSPI brings together representatives of statistical associations within Europe.
PSI has a joint award for Statistical Excellence within the Pharmaceutical Industry with the RSS. There are six-monthly meetings between representatives of both organisations to maintain good communication and identify opportunities to work together.
Recently PSI has linked with the Indian Association for Statistics in Clinical Trials (IASCT) and members of IASCT can join PSI at a reduced rate. PSI also welcomes members from any other countries, and from statisticians working in the wider clinical research and healthcare industries.
PSI has representatives on the Council of Biopharmaceutical Statisticians.
The Special Interest Groups include suitable representatives from, and interacts with, other organisations depending on the SIG topic. For instance, the Data Transparency SIG has had discussions with PhUSE members.
The PSI Careers and Academic Liaison Committee (CALC) promotes careers for statisticians and programmers within the pharmaceutical industry, and provides information and insights for those who might want to consider such a career through school and university activities, establishing links with relevant professional groups and via our Careers and Schools/Education websites.
The PSI Regulatory Committee is a joint PSI/EFSPI Committee which aims to provide an industry viewpoint on regulatory issues linked to statistics. This includes promoting best practice, reviewing and collating comments on regulatory policy and guidelines, driving debate on future guidance, and engaging with statisticians in European regulatory agencies, including the EMA Biostatistics Working Party (BSWP), as well as the statistical assessors at the Medicines & Healthcare products Regulatory Agency (MHRA).
PSI recognises that it is part of a wide community and therefore actively engages with the community.